Press Releases for 2022
ZOLL Awarded Diagnostic and Interventional Cardiology Catheter Agreement with Premier, Inc. for TherOx SuperSaturated Oxygen Therapy
Monday, October 31, 2022 in Chelmsford, Mass.
ZOLL Selected to Exhibit TherOx SSO2 Therapy at Vizient Innovative Technology ExchangeMonday, October 3, 2022 in Chelmsford, Mass.
First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack PatientsWednesday, September 7, 2022 in Chelmsford, Mass.
Centers for Medicare & Medicaid Services (CMS) Issue New ICD-10-PCS Code for ZOLL Medical's TherOx SSO2 TherapyThursday, July 14, 2022 in Chelmsford, Mass.
ZOLL Launches Next Generation MCT Solution, Shown to Improve Patient Management Decisions in Largest Ever MCT TrialMonday, March 21, 2022 in Chelmsford, Mass.
ZOLL Foundation Announces Grant Application Submission Deadline of March 31, 2022Thursday, January 13, 2022 in Chelmsford, Mass.